A detailed history of Helen Stephens Group, LLC transactions in Grifols Sa stock. As of the latest transaction made, Helen Stephens Group, LLC holds 86,466 shares of GRFS stock, worth $743,607. This represents 0.23% of its overall portfolio holdings.

Number of Shares
86,466
Previous 86,466 -0.0%
Holding current value
$743,607
Previous $544,000 40.99%
% of portfolio
0.23%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$6.27 - $7.7 $321,657 - $395,017
51,301 Added 145.89%
86,466 $544,000
Q2 2022

Jul 26, 2022

BUY
$10.6 - $13.28 $179,924 - $225,414
16,974 Added 93.31%
35,165 $418,000
Q4 2021

Jan 26, 2022

BUY
$10.21 - $15.27 $185,730 - $277,776
18,191 New
18,191 $204,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.84B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Helen Stephens Group, LLC Portfolio

Follow Helen Stephens Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Helen Stephens Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Helen Stephens Group, LLC with notifications on news.